Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
Regeneron(REGN) stock is priced at $793.53, giving the company a market capitalization of 83.91B. It carries a P/E multiple of 19.13 and pays a dividend yield of 44.4%.
On 2026-02-18, Regeneron(REGN) shares started trading at $806.77, with intraday highs of — and lows of —.
Trading volume for Regeneron(REGN) stock has reached 0, versus its average volume of 840.86K.
The stock's 52-week range extends from a low of $476.49 to a high of $821.11.
The stock's 52-week range extends from a low of $476.49 to a high of $821.11.
REGN News
In February 2026, Regeneron Pharmaceuticals announced that 36 abstracts from its immunology and inflammation portfolio were presented at the AAAAI Annual Meetin...
Regeneron Pharmaceuticals is set to present first in class Phase 3 antibody therapy data for cat and birch allergies at the 2026 AAAAI Annual Meeting. The pres...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals (REGN) is launching a Phase 3 trial called ROXI...
Analyst ratings
72%
of 29 ratingsMore REGN News
Regeneron Pharmaceuticals (REGN), Sanofi (SNYNF) announced an update on their ongoing clinical study. Sanofi and Regeneron are running a proof-of-concept Phase...
Advertisement What Regeneron’s Recent Trading Says About Investor Focus Regeneron Pharmaceuticals (REGN) has seen mixed share performance recently, with a 3.3...